Abstract:Introduction: This study aims at the biological profiling of Allium sativum , Zingiber officinale , Nigella sativa , Curcuma longa , Mentha piperita , Withania somnifera , Azadirachta indica , and Lawsonia inermis as alternatives against onychomycosis to combat the treatment challenges. Methods: An extract library of aqueous (DW), ethyl acetate (EA), and methanol (M) extracts was subjected to phytochemical and antioxidant colorimetric assays to gauge the ameliorating role of extracts against oxidative stress. RP-HPLC quantified therapeutically significant polyphenols. Antifungal potential (disc diffusion and broth dilution) against filamentous (dermatophytes and non-dermatophytes) and non-filamentous fungi ( yeasts ; Candida albicans ), synergistic interactions (checkerboard method) with terbinafine and amphotericin-B against resistant clinical isolates of dermatophytes ( Trichophyton rubrum and Trichophyton tonsurans ) and non-dermatophytes ( Aspergillus spp., Fusarium dimerum , and Rhizopus arrhizus ) , time-kill kinetics, and protein estimation (Bradford method) were performed to evaluate the potential of extracts against onychomycosis. Results: The highest total phenolic and flavonoid content along with noteworthy antioxidant capacity, reducing power, and a substantial radical scavenging activity was recorded for the extracts of Z. officinale . Significant polyphenolics quantified by RP-HPLC included rutin (35.71 ± 0.23 μg/mgE), gallic acid (50.17 ± 0.22 μg/mgE), catechin (93.04 ± 0.43 μg/mgE), syringic acid (55.63 ± 0.35 μg/mgE), emodin (246.32 ± 0.44 μg/mgE), luteolin (78.43 ± 0.18 μg/mgE), myricetin (29.44 ± 0.13 μg/mgE), and quercetin (97.45 ± 0.22 μg/mgE). Extracts presented prominent antifungal activity against dermatophytes and non-dermatophytes (MIC-31.25 μg/ml). The checkerboard method showed synergism with 4- and 8-fold reductions in the MICs of A. sativum , Z. officinale , M. piperita , L. inermis , and C. longa extracts and doses of amphotericin-B (Amp-B) and terbinafine (against non-dermatophytes and dermatophytes, respectively). Furthermore, the synergistic therapy showed a time-dependent decrease in fungal growth even after 9 and 12 h of treatment. The inhibition of fungal proteins was also observed to be higher with the treatment of synergistic combinations than with the extracts alone, along with the cell membrane damage caused by terbinafine and amp-B, thus making the resistant fungi incapable of subsisting. Conclusion: The extracts of A. sativum , Z. officinale , M. piperita , L. inermis , and C. longa have proven to be promising alternatives to combat oxidative stress, resistance, and other treatment challenges of onychomycosis.

Use of Caryophyllene Oxide As an Antifungal Agent in an in Vitro Experimental Model of Onychomycosis.

Comparison of the antifungal efficacy of terbinafine hydrochloride and ciclopirox olamine containing formulations against the dermatophyte Trichophyton rubrum in an infected nail plate model.

In Silico Drug Screening Based Development of Novel Formulations for Onychomycosis Management

In vitro antifungal oral drug and drug-combination activity against onychomycosis causative dermatophytes

Nail Lacquer Containing Origanum vulgare and Rosmarinus officinalis Essential Oils and Biogenic Silver Nanoparticles for Onychomycosis: Development, Characterization, and Evaluation of Antifungal Efficacy

Evaluation of activity and toxicity of combining clioquinol with ciclopirox and terbinafine in alternative models of dermatophytosis

Formulation of Tioconazole and Melaleuca alternifolia Essential Oil Pickering Emulsions for Onychomycosis Topical Treatment

Green natural nail polish modified with essential oils to treat onychomycosis

Antifungal and Anti-Biofilm Activity of Essential Oil Active Components against Cryptococcus neoformans and Cryptococcus laurentii

Activity of amorolfine or ciclopirox in combination with terbinafine against pathogenic fungi in onychomycosis—Results of an in vitro investigation

Sporicidal effect of amorolfine and other antimycotics used in the therapy of fungal nail infections

Design, Synthesis, and Antifungal Activity of 3-Substituted-2( 5H )-Oxaboroles

Transungual Penetration and Antifungal Activity of Prescription and Over-the-Counter Topical Antifungals: Ex Vivo Comparison

Comparison of In Vitro Antifungal Activities of Efinaconazole and Currently Available Antifungal Agents against a Variety of Pathogenic Fungi Associated with Onychomycosis

Novel Fluorinated 7-Hydroxycoumarin Derivatives Containing an Oxime Ether Moiety: Design, Synthesis, Crystal Structure and Biological Evaluation

The In Vitro Efficacy of Essential Oils and Antifungal Drugs Against Prototheca zopfii

Potent Antimicrobial Azoles: Synthesis, In Vitro and In Silico Study

Preparation and in vivo evaluation of a highly skin- and nail-permeable efinaconazole topical formulation for enhanced treatment of onychomycosis

Progess of topical antifungal agents for the treatment of onychomycosis

Ozone Therapy on Fungi that Cause Onychomycosis

Appraisal of selected ethnomedicinal plants as alternative therapies against onychomycosis: Evaluation of synergy and time-kill kinetics